Filter by: patients
What is Perlmutter's Brain Sustain?

BrainSustain, developed by David Perlmutter, MD, is said to reduce the production and damaging effects of excess free radicals in the brain that are associated with brain inflammation among such neurodegenerative disorders as, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, ALS.

Manufacturer's Perlmutter's Brain Sustain site

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 2 1 Efficacy_cant_tell
General health 2 1 Efficacy_cant_tell
Support brain health 1 0

See all 5 patients currently taking Perlmutter's Brain Sustain

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
2

Reported Dosages

  3 tbs. daily 4 daily 4 other daily 100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Perlmutter's Brain Sustain (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 1   Expense: 100%
Doctor's advice 1   Doctor's advice: 100%
Other 1   Other: 100%

See all 1 patient who’ve stopped taking Perlmutter's Brain Sustain

Currently Taking Perlmutter's Brain Sustain

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Perlmutter's Brain Sustain

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Perlmutter's Brain Sustain

Always
2 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Perlmutter's Brain Sustain

Very
0 0%
Somewhat
1 50%
A little
0 0%
Not at all
1 50%

Cost

Paid out of pocket

Cost of Perlmutter's Brain Sustain

$200+
0 0%
$100-199
0 0%
$50-99
1 100%
$25-49
0 0%
< $25
0 0%

Report created on May 28, 2012.